Are emerging PGD2 antagonists a promising therapy class for treating asthma?

File(s)

Are emerging PGD2 antagonists a promising therapy class for treating asthma.pdf (685 KB)

Accepted version

Show more

Author(s)

Farne, H

Jackson, DJ

Johnston, SL

Type

Journal Article

Date Issued

2016-10-16

Date Acceptance

2016-09-28

Citation

Expert Opinion on Emerging Drugs, 2016, 21 (4), pp.359-364

URI

http://hdl.handle.net/10044/1/41530

DOI

https://www.dx.doi.org/10.1080/14728214.2016.1244262

ISSN

1744-7623

Publisher

Taylor & Francis

Start Page

359

End Page

364

Journal / Book Title

Expert Opinion on Emerging Drugs

Volume

21

Issue

4

Copyright Statement

© 2016 Informa UK Limited, trading as Taylor & Francis Group. This is an Accepted Manuscript of an article published by Taylor & Francis Group in Expert Opinion on Emerging Drugs on 2 October 2016, available online at: http://www.tandfonline.com/10.1080/14728214.2016.1244262

Sponsor

GlaxoSmithKline Services Unlimited

Grant Number

n/a

Subjects

Asthma

CRTH2 antagonists

DP2 receptor antagonists

prostaglandin D2

Publication Status

Published